EMA drug evaluation spending to rise 6.5% to €80m, but EU funding falls
This article was originally published in Scrip
Executive Summary
The European Medicines Agency expects to spend €79.8 million on drug evaluation activities this year, a rise of 6.5%. This will account for almost 36% of its total expenditure of €222.5 million, which is also set to increase by 6.5%.